Novo Nordisk, Hims & Hers Reportedly End Obesity Drug Feud, Aim To Partner
The potential partnership comes a month after Novo sued Hims over obesity drug knockoffs. Also: A new study finds that generic versions of Ozempic and Wegovy could be sold for less than $3 a month.